Respiratory Care

Aerogen provide high performance aerosol drug delivery systems for every stage of respiratory care.

Respiratory patients respond faster with the Aerogen Ultra
which can help reduce hospital admissions from the ER.

 

No matter what the respiratory illness, for mechanically ventilated or spontaneous breathing patients, Aerogen has the appropriate aerosol drug delivery system for the effective treatment of your patients.

COPD

COPD patients breathe easy with Aerogen technology

Chronic Obstructive Pulmonary Disease (COPD) is one of the most serious lung diseases prevalent today affecting 65 million people worldwide.

From moderate chronic bronchitis to severe emphysema, COPD covers a range of debilitating lung conditions that limit airflow to the lungs.

The World Health Organisation (WHO) recognises that bronchodilator medications are crucial for symptomatic management of COPD and to effectively treat severe exacerbations of the disease.

Aerogen’s ground breaking technology and high performance aerosol drug delivery systems, the Aerogen Solo & the Aerogen Ultra, provide patients with quick and effective respiratory care at all stages of COPD.

  • 4 times more medication delivered to patients lungs1
  • Faster patient response means reduced treatment time2
  • Potential to reduce COPD hospital admissions from the ER
  • Quick & easy to set-up with no added flow
  • Significantly more medication in half the time3
  • Faster patient response means reduced treatment time2
  • Potential to reduce asthma related hospital admissions from the ER
  • Quick & easy to set-up with no added flow

Asthma

Aerogen gives targeted respiratory relief to asthma patients

Every day, millions of lives worldwide are affected by asthma. Difficulties in breathing mean serious health concerns and challenge the daily activities of sufferers with this respiratory condition. Healthcare experts realise that this global epidemic needs effective medical treatment:

  • According to the World Health Organisation (WHO), asthma is a chronic disease affecting 235 million people worldwide
  • A recent study undertaken by the Global Burden of Disease (GBD) in 2014 highlights asthma needs to become a global health priority
  • The WHO believes appropriate management can control this respiratory disease and give asthmatics a better quality of life

Aerogen’s ground breaking technology and high performance aerosol drug delivery systems, the Aerogen Solo & the Aerogen Ultra give targeted respiratory relief to asthmatics regardless of the severity of their condition.

Cystic Fibrosis

The Aerogen Ultra is ideal for the broad spectrum of CF medication including solutions, suspensions, proteins & peptides

Which CF medications can be delivered using Aerogen’s aerosol drug delivery technology?
Bronchodilators

Bronchodilators relax the muscle around your airways and are used to ease chest tightness. They can prepare your chest for chest physiotherapy or exercise by opening your airways.

Antibiotics

Antibiotics are used to treat, prevent and control infection. They should be taken after bronchodilators and chest physiotherapy.

Mucolytics DNase (Pulmozyme®)

DNase is used to make sputum thinner and easier to clear. It is normally prescribed once a day.

Osmotics

Hypertonic sodium chloride comes in different strengths; 3%, 6% or 7%. You may also know it as Nebusal® or Mucoclear®. It draws more water into the airways and sputum in the lung.

Corticosteroids

It is not common for people with cystic fibrosis to need aerosol delivered corticosteroids

Antifungals

Antifungals reduce the amount of fungal growth in the lungs. It is not common to nebulise antifungals but the CF team may ask patients to do this in certain circumstances.